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Understanding the mechanisms that control stem cell self-renewal and differentiation are at the core of stem
cell biology. In a recent issue ofCell, Hobbs et al. report that harnessingmTORC1 activity by the transcription
factor PLZF is crucial to maintain the self-renewing activity of germline progenitors.About 1000 spermatozoa are produced
with every breath of an adult man. Similar
to the organization of other regenerating
tissues such as blood, skin, and intestine,
mature spermatozoa are continuously
produced by differentiating proliferating
progenitors (spermatogonia) that are
derived from rare spermatogonial stem
cells (SSCs). These stem cells arise after
birth, persist throughout the male lifetime,
and are estimated to comprise about 1 in
3000 cells per testis. SSCs reside at the
base of the seminiferous tubules and are
surrounded by Sertoli cells that together
with other cells, including Leydig cells,
generate a stem cell niche (Oatley and
Brinster, 2008).
One of the key niche factors secreted by
Sertoli cells is the TGF-b superfamily
member glial cell-line derived neurotro-
phic factor (GDNF), which activates Src
family kinases and the PI3-kinase-Akt-
mTORC1 pathway in spermatogonial
progenitor cell (SPC) (Figure 1). Expres-
sion of GDNF is required for normal
spermatogenesis, and its overexpression
leads to the accumulation of spermato-
gonia (Meng et al., 2000). Moreover,
GDNF activity is essential to maintain
spermatogonial progenitor cells (SPC)
self-renewal in long-term in vitro cultures
(Kubota et al., 2004).Other signalingmole-
cules that appear to further promote SPC
self-renewal include bFGF, EGF, and
CSF-1. In addition, a number of transcrip-
tion factors includingPLZF,Taf4b,BCL6b,
ETV5, and Lhx1 have been suggested
to be important for the function of sper-
matogonial stem/progenitors (Oatley and
Brinster, 2008). However, it remains
largely unknown how the different signal-
ing components are connected to controlthe delicate balance between SPC self-
renewal and differentiation. In the current
issue of Cell, Hobbs et al. (2010) now
provide insights into this fascinating
process by suggesting that the harnessing
of mTORC1 activity by PLZF is crucial to
promote SPC self-renewal while simulta-
neously allowing for balanced differentia-
tion of the spermatogonial compartment.
The promyelocytic leukemia zinc finger
(PLZF) transcription factor has recently
been shown to be a crucial regulator of
germ cell function, as PLZF-deficient
mice undergo progressive germ cell loss
and testis atrophy associated with infer-
tility (Costoya et al., 2004). Taking advan-
tage of PLZF expression in early germline
progenitors, Hobbs et al. (2010) identified
by FACS a population of cells significantly
enriched for SPCs from juvenile testis.
Prepubertal PLZF-deficient testis con-
tained only about half as many of these
av-integrinneg Thy-1low c-Kitneg cells as
compared to wild-type. Moreover, con-
sistent with the observed progressive
loss of fertility in PLZF deficient mice,
PLZF-deficient cells show an increase in
the c-Kitpos population, indicating the
presence of a more proliferative and
differentiated population of SPCs.
To dissect the molecular mechanism
governing PLZF-mediated self-renewal of
SPCs, the authors took advantage of a
recently developed long-term SPC culture
protocol to generate control and Plzf/
SPCs cell lines. Interestingly, Plzf/
SPCs are physically larger than controls
due to hyperactive mTORC1 (mammalian
target of rapamycin complex 1). This size
phenotype is rescued by treatment of cells
with the mTORC1 inhibitor Rapamycin.
The authors ruled out an enhanced growthDevelopmental Cell 19factor response (GDNF, bFGF, and EGF)
as a cause of the augmented mTORC1
activity, as both Akt and Erk activities are
decreased. In addition, other upstream
regulators of mTORC1 such as Tsc1/2,
Rheb, or mTOR itself are unchanged in
mutant cells. However, a suppressor of
mTOR, Redd1, is substantially underex-
pressed in PLZF deficient SPCs. Redd1
inhibits mTORC1 through regulation of
TSC1/TSC2 and is induced by stress
stimuli such as hypoxia, DNA damage,
and oxidative stress (Ellisen, 2005). The
authors further showed that PLZF directly
activates the Redd1 promoter, resulting in
its increased expression, which mediates
subsequent mTORC1 inhibition (Figure 1).
These data explain why mTORC1
activity is increased in PLZF mutants, but
how is this associated with progressive
loss of SPC activity? Since GDNF sig-
naling is essential for SPC self-renewal,
the authors examined whether mTORC1
may negatively influence GDNF-mediated
signaling, particularly as PLZF mutants
show reduced Akt activity. Indeed, PLZF
mutant SPCs show reduced expression
of the two GDNF receptor components
GFRa1 and c-Ret, which could be
reversed by treatment with Rapamycin.
Since reduced GDNF signaling leads
to loss of SPC self-renewal, these data
suggest the presence of a negative
feedback loop between mTORC1 and
GDNF signaling that controls the balance
between self-renewal and differentiation
(Figure 1). In normal SPCs, PLZF activates
Redd1, which keeps mTORC1 activity
low and thus allows GDNF receptor medi-
ated Akt activation and self-renewal.
In the absence of PLZF, Redd1 is absent,
and mTORC1 becomes hyperactivated,, August 17, 2010 ª2010 Elsevier Inc. 187
Figure 1. Model of PLZF and mTORC1 Function in Spermatogonial Stem Cell (SSC)
Self-Renewal and Differentiation
Left, GDNF secreted by Sertoli cells activates via its receptors (GFRa1 and c-Ret) the PI3K/AKTpathway in
SSCs, which signals to mTORC1 to balance self-renewal and proliferation of SSCs. PLZF integrates
signaling pathways governing progenitor self-renewal via transcriptional control of Redd1, an mTORC1
inhibitor protein. Right, in the absence of PLZF, mTORC1 activity is enhanced due to decreased expres-
sion of Redd1. In this situation, a negative feedback loop from hyperactivated mTORC1 to the GDNF
receptor is established. This leads to defective self-renewal and exhaustion of the SSC pool as a result
of low PI3K/AKT signaling in response to niche-derived GDNF. As a result, differentiated spermatogonial
progenitors (Prog) are transiently increased. The mTORC1 inhibitor Rapamycin is able to rescue the SSC
exhaustion phenotype of Plzf/ mice.
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receptor components. This prevents suffi-
cient Akt activation in response to niche-
derived GDNF, thus tipping the balance
toward differentiation, resulting in the
progressive loss of SPCs. In agreement
with this model, the authors provided
data suggesting that Rapamycin treat-
ment of juvenile mice attenuates the
defect in Plzf/ mice, as shown by the
restoration of the SPC enriched av-integ-
rinneg Thy-1low c-Kitneg population. Finally,
prolonged Rapamycin treatment of wild-
type mice remarkably increases not only
SPC frequency, but also GFRa1 and
c-Ret expression, providing strong
support for the hypothesis that the level
of mTORC1 activity controls the balance
between SPC self-renewal and differenti-
ation in vivo.
Germline progenitors are not the only
cell type in which mTORC1, the central
mediator of cell growth, takescenter stage
in stem cell function. It has previously
been shown that hyperactivation of this
pathway in hematopoietic stem cells
(HSCs) leads to loss of quiescence, fol-
lowed by stem cell exhaustion (Gan and
DePinho, 2009). This is in agreement with188 Developmental Cell 19, August 17, 2010the finding that during homeostasis,
several stem cell types are maintained in
a stage of dormancy associated with
reduced metabolism (Wilson et al., 2008;
Fuchs, 2009). This may serve as a mecha-
nism to prevent the accumulation ofmuta-
tions in dangerously potent stem cells,
which could otherwise facilitate the initia-
tion of tumorigenesis. While stem cells
can be protected by staying transiently
dormant, progenitors need to rapidly
proliferate and upregulate their metabolic
pathways. To counteract the associated
risk of progenitor transformation, hyper-
active mTORC1 not only drives the
metabolism but appears to simulta-
neously shut-down the self-renewal pro-
cess. The findings of Hobbs et al. (2010)
suggest that this may, at least in part, be
mediated by desensitizing progenitors to
stem cell niche-derived signals, like
GDNF in the case of SPCs (Figure 1).
Although the present work unravels
someexciting new regulatory self-renewal
pathways and links niche-derived signals
via cytoplasmic regulators to nuclear tran-
scription factors, several important ques-
tions remain to be addressed. First, novel
markers are required to better identifyª2010 Elsevier Inc.the different stem/progenitor populations
present in the mammalian testis. Func-
tional reconstitution assays revealed that
the av-integrinneg Thy-1low c-Kitneg popu-
lation contains only about 1 functional
SSC per 80 cells (Hobbs et al., 2010).
Thus, it would be highly relevant to show
whether the PLZF-mTORC1 network
identified here indeed operates at the
most primitive SSC level, or is present
only in the pool of progenitors. Second,
PLZF seems to be a crucial SPC regulator
upstreamofmTORC1, but how its expres-
sion is controlled inSPCs remains unclear.
Third, is the identified PLZF-Redd1-
mTORC1 pathway also used by other
types of stem cells? As PLZF is also highly
expressed in human hematopoietic stem/
progenitors, where it restricts proliferation
and differentiation of myeloid progenitors,
this seems a likely possibility (Doulatov
et al., 2009).
Although the regulation of stem cell
self-renewal involves the interaction of
many cell type-specific regulatory cir-
cuits, some players like mTORC1 may
be commonly used by most stem cells.
The identification of more elements
controlling TORC1 activity will further
enhance our understanding of normal
and malignant stem cells.
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